# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA3101096 | F | Ratio of IC50 for human CRL2813 cells after 3 days by SRB assay in presence of HRI-targeting siRNA to IC50 for human CRL2813 cells after 3 days by SRB assay in presence of non-targeting siRNA | Homo sapiens | 2 | cell-based format | Scientific Literature | ||
2. | ALA3101097 | F | Antiproliferative activity against human CRL2813 cells after 3 days by SRB assay in presence of HRI-targeting siRNA | Homo sapiens | 6 | cell-based format | Scientific Literature | ||
3. | ALA3101098 | F | Antiproliferative activity against human CRL2813 cells after 3 days by SRB assay in presence of non-targeting siRNA | Homo sapiens | 6 | cell-based format | Scientific Literature | ||
4. | ALA3101099 | B | Activation of HRI in human CRL-2813-pBISA-DL(ATF-4) reporter cells assessed as concentration required to obtain F-luciferase expression/R-luciferase expression ratio 3 | Homo sapiens | 30 | assay format | Scientific Literature | ||
5. | ALA3101102 | B | Activation of HRI in human CRL-2813-pBISA-DL(ATF-4) reporter cells assessed as eIF2alpha phosphorylation after 8 to 32 hrs by dual-luciferase reporter gene assay | Homo sapiens | 4 | assay format | Scientific Literature | ||
6. | ALA3101113 | F | Cytotoxicity against human CRL2813 cells after 5 days by SRB assay | Homo sapiens | 48 | cell-based format | Scientific Literature | ||
7. | ALA3101114 | B | Activation of HRI in human CRL-2813-pBISA-DL(ATF-4) reporter cells assessed as reduction of ternary complex at 30 uM by dual-luciferase reporter gene assay relative to control | Homo sapiens | 48 | assay format | Scientific Literature |